| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2006PNAS..103..982S |
| P356 | DOI | 10.1073/PNAS.0510171102 |
| P8608 | Fatcat ID | release_kt6kvjbo7ffmbj3izxoz2l6w2u |
| P3181 | OpenCitations bibliographic resource ID | 711818 |
| P932 | PMC publication ID | 1348006 |
| P698 | PubMed publication ID | 16415157 |
| P5875 | ResearchGate publication ID | 7357511 |
| P50 | author | Dominic J. Smiraglia | Q38803257 |
| P2093 | author name string | Christoph Plass | |
| Gregory A Otterson | |||
| David E Schuller | |||
| James C Lang | |||
| Carl D Morrison | |||
| Romulo M Brena | |||
| Laura T Smith | |||
| Mauting Lin | |||
| P2860 | cites work | Two genetic hits (more or less) to cancer | Q22251289 |
| Basic helix-loop-helix transcription factor epicardin/capsulin/Pod-1 suppresses differentiation by negative regulation of transcription | Q24337398 | ||
| Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B | Q24555083 | ||
| Association of mesenchymal cells and immunoglobulins with differentiating epithelial cells | Q24800756 | ||
| Epithelial-mesenchymal transitions in tumour progression | Q27860487 | ||
| Worms gang up on bacteria | Q27860588 | ||
| The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis | Q28504626 | ||
| Capsulin: a novel bHLH transcription factor expressed in epicardial progenitors and mesenchyme of visceral organs | Q28507663 | ||
| The basic helix-loop-helix transcription factor capsulin controls spleen organogenesis | Q28510286 | ||
| Disrupted gonadogenesis and male-to-female sex reversal in Pod1 knockout mice | Q28585400 | ||
| Control of facial muscle development by MyoR and capsulin | Q28594434 | ||
| Tumour-cell invasion and migration: diversity and escape mechanisms | Q29547894 | ||
| Gene silencing in cancer in association with promoter hypermethylation | Q29617274 | ||
| Identification of bronchioalveolar stem cells in normal lung and lung cancer | Q29619267 | ||
| Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. | Q30884723 | ||
| DNA copy number losses in human neoplasms | Q33733232 | ||
| Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. | Q33888431 | ||
| A major lung cancer susceptibility locus maps to chromosome 6q23-25. | Q33910059 | ||
| Metastasis-suppressor genes: a review and perspective on an emerging field | Q33923801 | ||
| Induction and regulation of epithelial-mesenchymal transitions | Q34047215 | ||
| Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. | Q34095552 | ||
| Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors | Q34152353 | ||
| Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer | Q34188991 | ||
| Loss of heterozygosity analysis: practically and conceptually flawed? | Q34733395 | ||
| Methylation of the RASSF1A gene in human cancers | Q34835468 | ||
| Apicobasal polarization: epithelial form and function. | Q35595934 | ||
| Epithelial-mesenchymal interactions in the developing lung | Q35672544 | ||
| Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm | Q35740652 | ||
| Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors | Q35842229 | ||
| Mouse models for human lung cancer | Q36071893 | ||
| Identification of genes involved in epithelial-mesenchymal transition and tumor progression | Q38293825 | ||
| Bone morphogenetic protein 3B silencing in non-small-cell lung cancer. | Q40561449 | ||
| A human melanoma metastasis-suppressor locus maps to 6q16.3-q23. | Q40882273 | ||
| Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity | Q42809085 | ||
| Frequent promoter hypermethylation of RASSF1A and p16INK4a and infrequent allelic loss other than 9p21 in betel-associated oral carcinoma in a Vietnamese non-smoking/non-drinking female population | Q45249791 | ||
| Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus | Q47230963 | ||
| Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity | Q47937358 | ||
| Genomic alterations associated with malignancy in head and neck cancer. | Q51647782 | ||
| Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. | Q52831047 | ||
| The fundamental role of epigenetic events in cancer | Q56421597 | ||
| Specificity of 6q- markers and other recurrent deviations in human malignant salivary gland tumors | Q67946063 | ||
| Partial 6q deletion in a human salivary gland adenocarcinoma | Q69663956 | ||
| 6q- and loss of the Y chromosome--two common deviations in malignant human salivary gland tumors | Q70143825 | ||
| An expanded system of restriction landmark genomic scanning (RLGS Ver. 1.8) | Q72296653 | ||
| What defines a useful marker of metastasis in human cancer? | Q78140460 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | head and neck carcinoma | Q18554836 |
| neck cancer | Q18966654 | ||
| head and neck cancer | Q1783924 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 982-987 | |
| P577 | publication date | 2006-01-13 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer | |
| P478 | volume | 103 |
| Q36022241 | A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27. |
| Q38613802 | A regulation probability model-based meta-analysis of multiple transcriptomics data sets for cancer biomarker identification |
| Q28385552 | A robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinoma |
| Q36871625 | Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis |
| Q37177505 | Activator protein 2 alpha (AP2alpha) suppresses 42 kDa C/CAAT enhancer binding protein alpha (p42(C/EBPalpha)) in head and neck squamous cell carcinoma |
| Q58613614 | Adaptively capturing the heterogeneity of expression for cancer biomarker identification |
| Q35782788 | Adrenocortical stem and progenitor cells: implications for adrenocortical carcinoma |
| Q50002288 | Alteration of Epigenetic Regulation by Long Noncoding RNAs in Cancer |
| Q30537619 | Alterations in cardiac DNA methylation in human dilated cardiomyopathy |
| Q34607660 | Association of a transcription factor 21 gene polymorphism with hypertension |
| Q54979352 | Balance between senescence and apoptosis is regulated by telomere damage-induced association between p16 and caspase-3. |
| Q37797702 | Cancer Epigenome |
| Q33509293 | Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1. |
| Q34534982 | Clinical potential of TCF21 methylation in the diagnosis of renal cell carcinoma |
| Q34479335 | Clinicopathological significance and biological role of TCF21 mRNA in breast cancer |
| Q31028410 | Comparative mRNA and microRNA expression profiling of three genitourinary cancers reveals common hallmarks and cancer-specific molecular events |
| Q48098943 | Comparison of genome-wide analysis techniques to DNA methylation analysis in human cancer |
| Q35133698 | Coronary heart disease-associated variation in TCF21 disrupts a miR-224 binding site and miRNA-mediated regulation |
| Q37699374 | Curcumin increases exosomal TCF21 thus suppressing exosome-induced lung cancer |
| Q33769833 | Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene |
| Q36042596 | DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2. |
| Q28386334 | DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update |
| Q36640190 | Decitabine-induced demethylation of 5' CpG island in GADD45A leads to apoptosis in osteosarcoma cells |
| Q21134689 | Differential epigenetic regulation of TOX subfamily high mobility group box genes in lung and breast cancers |
| Q37389505 | Differential methylation of a short CpG-rich sequence within exon 1 of TCF21 gene: a promising cancer biomarker assay |
| Q36706060 | Differential transcriptomic analysis of spontaneous lung tumors in B6C3F1 mice: comparison to human non-small cell lung cancer |
| Q34846044 | Disease-related growth factor and embryonic signaling pathways modulate an enhancer of TCF21 expression at the 6q23.2 coronary heart disease locus |
| Q34163508 | Effect of cigarette smoke condensate on gene promoter methylation in human lung cells |
| Q37401725 | Epigenetic aspects in carcinomas of the head and neck |
| Q34201939 | Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma |
| Q34777193 | Epigenetic regulation of beta2-adrenergic receptor expression in TH1 and TH2 cells |
| Q21558627 | Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma |
| Q26749113 | Epigenetics in non-small cell lung cancer: from basics to therapeutics |
| Q33881333 | Estrogen-mediated epigenetic repression of large chromosomal regions through DNA looping |
| Q30945124 | Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor |
| Q33692420 | Gene signatures in wound tissue as evidenced by molecular profiling in the chick embryo model. |
| Q47129993 | Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancer |
| Q40368914 | Genome-wide analysis of DNA methylation and their associations with long noncoding RNA/mRNA expression in non-small-cell lung cancer |
| Q35032590 | Genome-wide analysis of differentially expressed genes and splicing isoforms in clear cell renal cell carcinoma |
| Q34731480 | Genome-wide epigenetic modifications in cancer. |
| Q21134921 | Genomic and epigenomic responses to chronic stress involve miRNA-mediated programming |
| Q34378398 | Genomics meets proteomics: identifying the culprits in disease |
| Q36288148 | High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications |
| Q35720707 | Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay |
| Q35859326 | IL-6 trans-signaling increases expression of airways disease genes in airway smooth muscle |
| Q36791714 | Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer |
| Q91755842 | Identification of potential diagnostic and therapeutic target genes for lung squamous cell carcinoma |
| Q35128048 | Isolation and characterization of the TIGA genes, whose transcripts are induced by growth arrest |
| Q40492521 | Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways. |
| Q34504623 | Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancers |
| Q33644599 | MicroRNA-205 promotes cell invasion by repressing TCF21 in human ovarian cancer |
| Q92237374 | MicroRNA-30-3p Suppresses Inflammatory Factor-Induced Endothelial Cell Injury by Targeting TCF21 |
| Q64116711 | MicroRNA-3648 Is Upregulated to Suppress TCF21, Resulting in Promotion of Invasion and Metastasis of Human Bladder Cancer |
| Q37103514 | Mining the epigenome for methylated genes in lung cancer |
| Q55396475 | Multiple biological functions of transcription factor 21 in the development of various cancers. |
| Q38150711 | Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer |
| Q33775898 | New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells |
| Q33581231 | Oncogenic BRAFV600E induces expression of neuronal differentiation marker MAP2 in melanoma cells by promoter demethylation and down-regulation of transcription repressor HES1. |
| Q35841917 | Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy |
| Q39211960 | POD-1 binding to the E-box sequence inhibits SF-1 and StAR expression in human adrenocortical tumor cells |
| Q40483995 | POD-1/TCF21 Reduces SHP Expression, Affecting LRH-1 Regulation and Cell Cycle Balance in Adrenocortical and Hepatocarcinoma Tumor Cells. |
| Q36322285 | POD-1/Tcf21 overexpression reduces endogenous SF-1 and StAR expression in rat adrenal cells |
| Q33775468 | Phenotype-specific CpG island methylation events in a murine model of prostate cancer |
| Q35887461 | Principles for the post-GWAS functional characterization of cancer risk loci |
| Q33700571 | Prognostic significance of TCF21 mRNA expression in patients with lung adenocarcinoma. |
| Q55334108 | Promoter methylation of TCF21 may repress autophagy in the progression of lung cancer. |
| Q91940161 | Promoter methylation of the candidate tumor suppressor gene TCF21 in myelodysplastic syndrome and acute myeloid leukemia |
| Q54193729 | Protein expression and promoter methylation of the candidate biomarker TCF21 in gastric cancer. |
| Q86490397 | Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma |
| Q50853512 | Reactive oxygen species-dependent down-regulation of tumor suppressor genes PTEN, USP28, DRAM, TIGAR, and CYLD under oxidative stress. |
| Q30481256 | Restriction landmark genomic scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinations. |
| Q38019157 | Role of DNA methylation in head and neck cancer |
| Q26801268 | Role of DNA methylation in renal cell carcinoma |
| Q64239667 | Role of microRNA-92a in metastasis of osteosarcoma cells in vivo and in vitro by inhibiting expression of TCF21 with the transmission of bone marrow derived mesenchymal stem cells |
| Q37295632 | Sumoylation of TCF21 downregulates the transcriptional activity of estrogen receptor-alpha |
| Q37712367 | TCF21 functions as a tumor suppressor in colorectal cancer through inactivation of PI3K/AKT signaling |
| Q36140638 | TCF21 hypermethylation in genetically quiescent clear cell sarcoma of the kidney |
| Q47591804 | TCF21 hypermethylation regulates renal tumor cell clonogenic proliferation and migration |
| Q36763079 | The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells |
| Q24318687 | The human homolog of the Drosophila headcase protein slows down cell division of head and neck cancer cells |
| Q37203595 | The multi-omic landscape of transcription factor inactivation in cancer |
| Q33888122 | Transcription Factor 21 (TCF21) rs12190287 Polymorphism is Associated with Osteosarcoma Risk and Outcomes in East Chinese Population |
| Q90266601 | Transforming Growth Factor-β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma |
| Q37219171 | Uncovering Driver DNA Methylation Events in Nonsmoking Early Stage Lung Adenocarcinoma |
| Q52717033 | Withaferin A and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanisms. |
| Q55451366 | [Effects of tumor suppressor gene TCF21 on the proliferation, migration and apoptosis of A549 cells]. |
| Q35438574 | jNMFMA: a joint non-negative matrix factorization meta-analysis of transcriptomics data |
| Q54280971 | miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer. |
| Q92730465 | miR526b and miR655 Induce Oxidative Stress in Breast Cancer |
Search more.